Raymond Debbane - Jun 3, 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Stock symbol
LXRX
Transactions as of
Jun 3, 2025
Transactions value $
$0
Form type
4
Date filed
6/3/2025, 04:20 PM
Previous filing
May 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DEBBANE RAYMOND Director 2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS /s/ Raymond Debbane 2025-06-03 0001053890

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +104K $0.00 104K Jun 3, 2025 Common Stock 104K $0.62 Direct F1
transaction LXRX Restricted Stock Units Award $0 +89.3K $0.00 89.3K Jun 3, 2025 Common Stock 89.3K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.
F2 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.